Published October 27, 2026 | Version v1

脳のシステム工学・制御理論的観点から考察する精神病のメカニズム 第13報 抗精神病薬の機序と問題点の考察/An Examination of the Mechanisms of Psychosis from the Perspective of Systems Engineering and Control Theory of the Brain Report No. 13: A Consideration of the Mechanisms and Issues Surrounding Antipsychotic Medication

Authors/Creators

  • 1. Independent Researcher

Description

【Abstract (English)】Antipsychotic drugs primarily suppress excessive neural transmission by blocking dopamine D2 receptors and serotonin receptors, thereby eliminating positive symptoms. However, the true underlying cause of the condition is not ‘excessive dopamine production’, but rather a breakdown in frontal lobe feedback control (excessive amplification of noise and oscillation) associated with, for example, GABA deficiency.

Consequently, the forced blockade of dopamine receptors induces a ‘brain safe mode’ (global functional suppression), which indiscriminately attenuates even normal signalling pathways. Furthermore, the mild anaesthetic effect and GABA-like central inhibition exerted by antipsychotic drugs not only promote excessive pruning of frontal lobe synapses in the long term, but also physically inhibit the processes of ‘thinking, learning and synaptic regeneration’ mediated through interpersonal relationships and environmental stimuli. The fact that, according to an international collaborative study by the World Health Organisation (WHO), the long-term outcomes (recovery rates) for schizophrenia are better in developing countries, where access to medication is restricted, than in developed countries, clearly illustrates the risk that long-term administration of antipsychotic drugs poses to recovery.

【概要(日本語)】抗精神病薬は、主にドパミンD2受容体およびセロトニン受容体を遮断することで過剰な情報伝達を抑え、陽性症状を消失させる。しかし、病態の真の根底には「過剰なドパミン産生」が存在するわけではなく、GABA不全等に伴う前頭葉のフィードバック制御の破綻(ノイズの過剰増幅・発振)が存在する。

したがって、ドパミン受容体の強制遮断は、正常な情報伝達シグナルまでをも一括して減衰させる「脳のセーフモード化(全体的機能抑制)」をもたらす。さらに、抗精神病薬が持つ弱麻酔作用・GABA様中枢抑制は、前頭葉シナプスの過剰刈り込みを長期的に推し進めると同時に、人間関係や環境刺激を通じた「思考・学習・シナプス再生」のプロセスを物理的に阻害する。世界保健機関(WHO)の国際共同調査において、薬物アクセスが制限される発展途上国の方が先進国よりも統合失調症の長期的転帰(回復率)が良好であるという事実は、抗精神病薬の長期投与が持つ回復阻害リスクを端的に象徴している。

Files

第13報.pdf

Files (496.1 kB)

Name Size
md5:14c7ff3d8737ab24cf947a429651db01
496.1 kB Preview Download